Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
50.31
+3.81 (8.19%)
At close: Nov 22, 2024, 4:00 PM
50.75
+0.44 (0.87%)
After-hours: Nov 22, 2024, 5:09 PM EST
Janux Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Cash & Equivalents | 26.75 | 19.21 | 51.43 | 35.58 | 7.81 | 0.66 |
| Short-Term Investments | 631.28 | 324.82 | 275.59 | 339.38 | - | - |
| Cash & Short-Term Investments | 658.03 | 344.03 | 327.02 | 374.97 | 7.81 | 0.66 |
| Cash Growth | 88.16% | 5.20% | -12.79% | 4699.24% | 1087.39% | - |
| Accounts Receivable | - | - | - | - | 8 | - |
| Other Receivables | 4.45 | 2.2 | 0.7 | 0.2 | - | - |
| Receivables | 4.45 | 2.2 | 0.7 | 0.2 | 8 | - |
| Prepaid Expenses | 3.84 | 3.01 | 4.72 | 1.85 | 0.25 | - |
| Total Current Assets | 666.32 | 349.24 | 332.44 | 377.02 | 16.06 | 0.66 |
| Property, Plant & Equipment | 25.06 | 27.84 | 29.37 | 1.6 | 0.16 | 0.02 |
| Other Long-Term Assets | 3.64 | 3.33 | 2.21 | 1.21 | - | - |
| Total Assets | 695.02 | 380.41 | 364.01 | 379.82 | 16.22 | 0.68 |
| Accounts Payable | 2.46 | 2.42 | 2.16 | 2.46 | 0.43 | 0.27 |
| Accrued Expenses | 13.02 | 7.39 | 8.18 | 3.78 | 0.75 | 0.36 |
| Short-Term Debt | - | - | - | - | - | 4 |
| Current Portion of Leases | 1.69 | 1.52 | 0.76 | 0.19 | - | - |
| Current Unearned Revenue | - | 1.71 | 5.41 | 5.16 | 1.95 | - |
| Other Current Liabilities | - | - | - | 1.2 | 0.05 | - |
| Total Current Liabilities | 17.17 | 13.03 | 16.51 | 12.8 | 3.18 | 4.63 |
| Long-Term Leases | 21.74 | 23.03 | 24.54 | - | - | - |
| Long-Term Unearned Revenue | - | - | 2.22 | 0.7 | 6.05 | - |
| Total Liabilities | 38.92 | 36.06 | 43.27 | 13.5 | 9.23 | 4.63 |
| Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0 | 0 |
| Additional Paid-In Capital | 865.76 | 512.4 | 432.7 | 413.97 | 0.1 | 0.01 |
| Retained Earnings | -217.54 | -168.76 | -110.47 | -47.41 | -14.74 | -7.96 |
| Comprehensive Income & Other | 7.83 | 0.67 | -1.54 | -0.27 | - | - |
| Total Common Equity | 656.1 | 344.35 | 320.74 | 366.33 | -14.64 | -7.94 |
| Shareholders' Equity | 656.1 | 344.35 | 320.74 | 366.33 | 6.99 | -3.95 |
| Total Liabilities & Equity | 695.02 | 380.41 | 364.01 | 379.82 | 16.22 | 0.68 |
| Total Debt | 23.43 | 24.54 | 25.31 | 0.19 | - | 4 |
| Net Cash (Debt) | 634.6 | 319.49 | 301.71 | 374.77 | 7.81 | -3.34 |
| Net Cash Growth | 95.37% | 5.89% | -19.49% | 4696.76% | - | - |
| Net Cash Per Share | 12.39 | 7.26 | 7.28 | 15.93 | 8.54 | -4.99 |
| Filing Date Shares Outstanding | 52.48 | 51.65 | 41.76 | 41.24 | 1.26 | 0.67 |
| Total Common Shares Outstanding | 52.33 | 46.24 | 41.62 | 41.24 | 1.26 | 0.67 |
| Working Capital | 649.15 | 336.21 | 315.93 | 364.22 | 12.88 | -3.97 |
| Book Value Per Share | 12.54 | 7.45 | 7.71 | 8.88 | -11.64 | -11.87 |
| Tangible Book Value | 656.1 | 344.35 | 320.74 | 366.33 | -14.64 | -7.94 |
| Tangible Book Value Per Share | 12.54 | 7.45 | 7.71 | 8.88 | -11.64 | -11.87 |
| Machinery | 9.82 | 9.87 | 7.91 | 1.4 | 0.18 | 0.03 |
| Construction In Progress | - | - | - | 0.14 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.